Factors Associated with Smoking Cessation in Oncological Patients at INCA
DOI:
https://doi.org/10.32635/2176-9745.RBC.2026v72n2.5538Keywords:
Tobacco Use Disorder, Smoking Cessation, Demography, NeoplasmsAbstract
-
Introduction: Smoking in oncological patients leads to negative consequences, such as reduced survival, increased risk of surgical complications, lower therapeutic efficacy, and higher probability of recurrence. Despite this, many cancer patients continue to smoke even after diagnosis. This scenario is aggravated by the fact that many patients do not receive adequate guidance about the risks related to continuing to smoke during oncological treatment. Objective: To evaluate the sociodemographic and clinical factors associated with smoking cessation among oncological patients undergoing treatment for nicotine dependence, treated at the National Cancer Institute (INCA). Method: Retrospective cohort study using data from the electronic medical records of the Center for Studies on Nicotine Dependence Treatment at INCA. Sociodemographic, clinical, and treatment process-related variables were analyzed. Results: Of 211 patients analyzed, 31.8% (n=67) achieved cessation, with an adjusted odds ratio (OR) of 2.58 (95% CI 1.31-5.11) for attendance at ≥4 consultations, with a higher success rate among those who underwent surgical procedures. Self-declared Black individuals and those not living with a partner showed a lower probability of smoking cessation. Conclusion: The findings highlight the need to raise awareness and train health professionals in addressing smoking in the oncological context, reinforcing its relevance as an essential component of comprehensive care. It is fundamental to consider sociodemographic inequalities in planning personalized therapeutic strategies, respecting the uniqueness and vulnerability of cancer patients.
Downloads
References
Islami F, Goding Sauer A, Miller KD, et al. Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States. CA Cancer J Clin. 2018;68(1):31-54. doi: https://www.doi.org/10.3322/caac.21440
Schaefers C, Seidel C, Bokemeyer F, et al. The prognostic impact of the smoking status of cancer patients receiving systemic treatment, radiation therapy, and surgery: a systematic review and meta-analysis. Eur J Cancer. 2022;172:130-7. doi: https://www.doi.org/10.1016/j.ejca.2022.05.027
Bergman M, Fountoukidis G, Smith D, et al. Effect of smoking on treatment efficacy and toxicity in patients with cancer: a systematic review and meta-analysis. Cancers (Basel). 2022;14(17):4117. doi: https://www.doi.org/10.3390/cancers14174117
Lu D, Zhou X, Sun H, et al. Risk of second primary cancer in patients with head and neck squamous cell carcinoma: a systemic review and meta-analysis. Clin Oral Investig. 2023;27(9):4897-910. doi: https://www.doi.org/10.1007/s00784-023-05066-3
Badiani S, Diab J, Woodford E, et al. Impact of preoperative smoking on patients undergoing right hemicolectomies for colon cancer. Langenbecks Arch Surg. 2022;407(5):2001-9. doi: https://www.doi.org/10.1007/s00423-022-02486-9 Erratum in: Langenbecks Arch Surg. 2022;407(8):3889. doi: https://www.doi.org/10.1007/s00423-022-02528-2
Townsend AN, Denton A, Gohel N, et al. An association between comorbidities and postsurgical complications in adults who underwent esophagectomy. Cureus. 2023;15(3):e36395. doi: https://www.doi.org/10.7759/cureus.36395
Chen M, Liang H, Chen M, et al. Risk factors for surgical site infection in patients with gastric cancer: a meta-analysis. Int Wound J. 2023;20(9):3884-97. doi: https://www.doi.org/10.1111/iwj.14264
Price SN, Palmer AM, Fucito LM, et al. Tobacco use and cancer-related symptom burden: analysis of the us population assessment of tobacco and health study. Cancer. 2023;129(15):2385-94. doi: https://www.doi.org/10.1002/cncr.34746
Gali K, Aryal S, Bokemeyer F, et al. Determinants of persistent smoking among breast cancer survivors. Prev Med Rep. 2024;48:102913. doi: https://www.doi.org/10.1016/j.pmedr.2024.102913
Taborelli M, Dal Maso L, Zucchetto A, et al. Prevalence and determinants of quitting smoking after cancer diagnosis: a prospective cohort study. Tumori. 2022;108(3):213-22. doi: https://www.doi.org/10.1177/03008916211009301
Burke L, Miller LA, Saad A, et al. Smoking behaviors among cancer survivors: an observational clinical study. J Oncol Pract. 2009;5(1):6-9. doi: https://www.doi.org/10.1200/JOP.0912001
Ramaswamy AT, Toll BA, Chagpar AB, et al. Smoking, cessation, and cessation counseling in patients with cancer: a population-based analysis. Cancer. 2016;122(8):1247-53. doi: https://www.doi.org/10.1002/cncr.29851
Chang EHE, Braith A, Hitsman B, et al. Treating nicotine dependence and preventing smoking relapse in cancer patients. Expert Rev Qual Life Cancer Care. 2017;2(1):23-39. doi: https://www.doi.org/10.1080/23809000.2017.1271981
Cinciripini PM, Karam-Hage M, Kypriotakis G, et al. Association of a comprehensive smoking cessation program with smoking abstinence among patients with cancer. JAMA Netw Open. 2019;2(9):e1912251. doi: https://www.doi.org/10.1001/jamanetworkopen.2019.12251
Schnoll RA, Rothman RL, Newman H, et al. Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients. Psychooncology. 2004;13(5):346-58. doi: https://www.doi.org/10.1002/pon.756
Linden W, Vodermaier A, Mackenzie R, et al. Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age. J Affect Disord. 2012;141(2-3):343-51. doi: https://www.doi.org/10.1016/j.jad.2012.03.025
Berg CJ, Thomas AN, Mertens AC, et al. Correlates of continued smoking versus cessation among survivors of smoking-related cancers. Psychooncology. 2013;22(4):799-806. doi: https://www.doi.org/10.1002/pon.3077
Bokemeyer F, Lebherz L, Bokemeyer C, et al. Smoking patterns and the intention to quit in German patients with cancer: study protocol for a cross-sectional observational study. BMJ Open 2023;13:e069570. doi: https://www.doi.org/10.1136/bmjopen-2022-069570
Fitzpatrick P, Bhardwaj N, Masalkhi M, et al. Provision of smoking cessation support for patients following a diagnosis of cancer in Ireland. Prev Med Rep. 2023;32:102158. doi: https://www.doi.org/10.1016/j.pmedr.2023.102158
Cox LS, Africano NL, Tercyak KP, et al. Nicotine dependence treatment for patients with cancer. Cancer. 2003;98(3):632-44. doi: https://www.doi.org/10.1002/cncr.11538 Erratum in: Cancer. 2003;98(5):1104.
Sharp L, Johansson H, Fagerström K, et al. Smoking cessation among patients with head and neck cancer: cancer as a 'teachable moment'. Eur J Cancer Care (Engl). 2008;17(2):114-9. doi: https://www.doi.org/10.1111/j.1365-2354.2007.00815.x
Mendes ACR, Toscano CM, Barcellos RMS, et al. Custos do programa de tratamento do tabagismo no Brasil. Rev Saude Publica. 2016;50:66.
Ministério da Saúde (BR). Portaria Conjunta nº 10, de 16 de abril de 2020. Aprova o Protocolo Clínico e Diretrizes Terapêuticas do Tabagismo. Diário Oficial da União [Internet], Brasília, DF. 2020 abr 24 [acesso 2023 nov 15]; Edição 78; Seção 1:214. Disponível em: https://www.gov.br/conitec/pt-br/midias/relatorios/portaria/2020/portariaconjunta_sctie_saes_10_2020.pdf
Organização Mundial da Saúde. ICD-10: international statistical classification of diseases and related health problems tenth revision [Internet]. 2. ed. Geneva: World Health Organization; 2004 [acesso 2024 maio 15]. Disponível em: https://iris.who.int/bitstream/handle/10665/42980/9241546530_eng.pdf?sequence=1&isAllowed=y
Brierley JD, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8. ed. Oxford; Hoboken: John Wiley & Sons, Inc.; 2017.
Burris JL, Borger TN, Shelton BJ, et al. tobacco use and tobacco treatment referral response of patients with cancer: implementation outcomes at a National Cancer Institute-Designated Cancer Center. JCO Oncol Pract. 2022;18(2):e261-70. doi: https://www.doi.org/10.1200/OP.20.01095
Taylor KL, Webster MA, Philips JG, et al. Integrating tobacco use assessment and treatment in the oncology setting: quality improvement results from the georgetown lombardi smoking treatment and recovery program. Curr Oncol. 2023;30(4):3755-75. doi: https://www.doi.org/10.3390/curroncol30040285
Park ER, Perez GK, Regan S, et al. Effect of sustained smoking cessation counseling and provision of medication vs shorter-term counseling and medication advice on smoking abstinence in patients recently diagnosed with cancer: a randomized clinical trial. JAMA. 2020;324(14):1406-18. doi: https://www.doi.org/10.1001/jama.2020.14581
Pluta K, Hohl SD, D'Angelo H, et al. Data envelopment analysis to evaluate the efficiency of tobacco treatment programs in the NCI Moonshot Cancer Center Cessation Initiative. Implement Sci Commun. 2023;4(1):50. doi: https://www.doi.org/10.1186/s43058-023-00433-3
Westergaard SA, Rupji M, Franklin LE, et al. Engagement and outcomes of cancer patients referred to a tobacco cessation program at a National Cancer Institute-designated cancer center. Cancer Med. 2023;12(6):7339-47. doi: https://www.doi.org/10.1002/cam4.5423
Heatherton TF, Kozlowski LT, Frecker RC, et al. The fagerström test for nicotine dependence: a revision of the fagerström tolerance questionnaire. Br J Addict. 1991;86(9):1119-27. doi: https://www.doi.org/10.1111/j.1360-0443.1991.tb01879.x
Prochaska JO, DiClemente CC, Norcross JC. In search of how people change. applications to addictive behaviors. Am Psychol. 1992;47(9):1102-14. doi: https://www.doi.org/10.1037//0003-066x.47.9.1102
Pawlina MM, Rondina RC, Espinosa MM, et al. Abandonment of nicotine dependence treatment: a cohort study. Sao Paulo Med J. 2016;134(1):47-55. doi: https://www.doi.org/10.1590/1516-3180.2015.00830309
R: The R Project for Statistical Computing [Internet]. Version 4.1.2 [place unknown]: The R foundation. 2021 Nov 2 - [acesso 2025 set 6]. Available from : https://www.r-project.org/
Conselho Nacional de Saúde (BR). Resolução n° 466, de 12 de dezembro de 2012. Aprova as diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Diário Oficial da União, Brasília, DF. 2013 jun 13; Seção I:59.
Ong J, Plueckhahn I, Cruickshank D, et al. A smoking cessation programme for current and recent ex-smokers following diagnosis of a potentially curable cancer. Intern Med J. 2016;46(9):1089-96. doi: https://www.doi.org/10.1111/imj.13172
Notier AE, Hager P, Brown KS, et al. Using a quitline to deliver opt-out smoking cessation for cancer patients. JCO Oncol Pract. 2020;16(6):e549-56. doi: https://www.doi.org/10.1200/JOP.19.00296
Carroll AJ, Veluz-Wilkins AK, Blazekovic S, et al. Cancer-related disease factors and smoking cessation treatment: analysis of an ongoing clinical trial. Psychooncology. 2018;27(2):471-6. doi: https://www.doi.org/10.1002/pon.4483
Rettig EM, Fakhry C, Hales RK, et al. Pilot randomized controlled trial of a comprehensive smoking cessation intervention for patients with upper aerodigestive cancer undergoing radiotherapy. Head Neck. 2018;40(7):1534-47. doi: https://www.doi.org/10.1002/hed.25148
Gummerson SP, Lowe JT, Taylor KL, et al. The characteristics of patients who quit smoking in the year following a cancer diagnosis. J Cancer Surviv. 2022;16(1):111-8. doi: https://www.doi.org/10.1007/s11764-021-01009-7
Shen MJ, Peterson EB, Costas-Muñiz R, et al. The effects of race and racial concordance on patient-physician communication: a systematic review of the literature. J Racial Ethn Health Disparities. 2018;5(1):117-40. doi: https://www.doi.org/10.1007/s40615-017-0350-4
Landrine H, Corral I, Campbell KM. Racial disparities in healthcare provider advice to quit smoking. Prev Med Rep. 2018;10:172-5. doi: https://www.doi.org/10.1016/j.pmedr.2018.03.003
King AC, Cao D, Southard CC, et al. Racial differences in eligibility and enrollment in a smoking cessation clinical trial. Health Psychol. 2011;30(1):40-8. doi: https://www.doi.org/10.1037/a0021649
Boccolini CS, Boccolini PM, Damacena GN, et al. Factors associated with perceived discrimination in health services of Brazil: results of the Brazilian National Health Survey, 2013. Cien Saude Colet. 2016;21(2):371-8. doi: https://www.doi.org/10.1590/1413-81232015212.19412015
Weech-Maldonado R, Hall A, Bryant T, et al. The relationship between perceived discrimination and patient experiences with health care. Med Care. 2012;50(9 Suppl 2):S62-8. doi: https://www.doi.org/10.1097/MLR.0b013e31825fb235
Hawari FI, Abu Alhalawa MA, Alshraiedeh RH, et al. Supporting smokers in difficult settings: suggestions for better education and counseling in Cancer Centers in Jordan. Curr Oncol. 2022;29(12):9335-48. doi: https://www.doi.org/10.3390/curroncol29120732
Schnoll RA, Malstrom M, James C, et al. Correlates of tobacco use among smokers and recent quitters diagnosed with cancer. Patient Educ Couns. 2002;46(2):137-45. doi: https://www.doi.org/10.1016/s0738-3991(01)00157-4
Heiden BT, Eaton DB Jr, Chang SH, et al. Assessment of duration of smoking cessation prior to surgical treatment of non-small cell lung cancer. Ann Surg. 2023;277(4):e933-40. doi: https://www.doi.org/10.1097/SLA.0000000000005312
Nayan S, Gupta MK, Strychowsky JE, et al. Smoking cessation interventions and cessation rates in the oncology population: an updated systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2013;149(2):200-11. doi: https://www.doi.org/10.1177/0194599813490886
Alcantara LS, Caboclo GWMF, Borges VLG, et al. História do programa INCA livre do cigarro e seus desdobramentos no programa nacional de controle do tabagismo: avanços e desafios da abordagem assistencial. Rev Bras Cancerol. 2025;71(3):e-155236. doi: https://doi.org/10.32635/2176-9745.RBC.2025v71n3.5236
Published
How to Cite
Issue
Section
License
Os direitos morais e intelectuais dos artigos pertencem aos respectivos autores, que concedem à RBC o direito de publicação.
This work is licensed under a Creative Commons Attribution 4.0 International License.
